Industry sectors

Research rewired: Merging care and research information to improve knowledge discovery

Listen to the Pharma 2020 podcast: The vision - which path will you take?

Publications, thought leadership & studies


Pharma 2020: Virtual R&D - Which path will you take? ( June 2008)	Super Cluster: Ideas, perspectives, and trends shaping the global impact of the Massachusetts life sciences industry ( June 2008)	IFRS - Issues and Solutions for the Pharmaceutical and Life Sciences Industries – Vol I & II UPDATES ( April 2008)	Pharma 2020: The vision - Which path will you take? ( June 2007)

Pharma 2020: Virtual R&D - Which path will you take? - June 2008

Pharma 2020: The vision - Which path will you take? - June 2007

Pharma 2020: The vision - Which path will you take? - Executive summary - June 2007

Recapturing the Vision: Restoring trust in the pharmaceutical industry by translating expections into actions - January 2007

Recapturing the vision: Integrity driven performance in the pharmaceutical industry* - June 2005

Super Cluster: Ideas, perspectives, and trends shaping the global impact of the Massachusetts life sciences industry - June 2008

California’s Biomedical Industry 2008 Report - January 2008

Creating a climate of innovation: the health industry's most challenging paradox - September 2007

CEE tax notes: Working cross-border - August 2007

Gearing up for a global gravity shift*
growth, risk and learning in the Asia pharmaceutical market - May 2007

Improving America's Health IV: A survey of the working relationship between the life science industry and the FDA (Food and Drug Administration Modernization Act of 1997) - May 2007

Super Cluster: Ideas, perspectives and updates from the Massachusetts life sciences industry - April 2007

2006 medical device and venture capital - money tree report - April 2007

Challenges of complying with the AdvaMed Code - March 2007

Working Towards Wellness: Accelerating the prevention of chronic disease - February 2007

Unlocking the power of pharmacovigilance: An adaptive approach to an evolving drug safety environment - January 2007

California's biomedical industry report 2006 - October 2006
Investing in China's pharmaceutical industry - March 2006
Clinical trials in Poland – main barriers to the industry development - February 2006 (178 kb - Adobe Acrobat file)
New England biotech and medical device companies thriving as venture capital investment hits near-record US$1.26B in 2006 - January 2006
The factors fueling rising healthcare costs 2006 - January 2006
The American Jobs Creation Act of 2004: Application of section 199 to the pharmaceutical industry - January 2006
Revenue recognition disclosures in the pharmaceutical industry - November 2005
A better shape for the future: Building value through integration and partnerships. - June 2005
Personalized Medicine: The Emerging Pharmacogenomics Revolution - February 2005
PAT: Evolution or revolution? Charting the development of process analytical technology, "Pharmaceutical Manufacturing Packing Sourcer (PMPS) Journal" - November 2004
PricewaterhouseCoopers report shows the impact of Medicare prescription drug coverage on low-income beneficiaries. - July 2004
The value of pharmacy benefit management and the national cost impact of proposed pharmacy benefit management (PBM) legislation - July 2004
TS insights - The new Medicare prescription drug law - July 2004
The potential impact of Medicare prescription drug benefit on pharmaceutical companies - March 2004
EU tariff suspension opportunities for pharmaceutical companies - May 2003

Interviews and Articles

Article: Journal of pharmaceutical innovation - Sept/Oct 2006: The need for a broader perspective if process analytical technology implementation is to be successful in the pharmaceutical sector - February 2008

Article: Power of Pharmacovigilance - MedAd News - November 2006

Interview: Malvinder Singh, Ranbaxy CEO - January 2007

Article: Pharmaceutical Technology Europe: The Business Benefits of Implementing PAT - July 2006

Pharmaceutical sector M&A Insights 2006-2007 - September 2007
Corporate finance insights pharmaceutical sector 2005/2006 - June 2006
Pharmaceutical sector insights: 2004 - 2005 - June 2005

Pharmaceutical sector insights: 2003 - 2004 - June 2004

International Financial Reporting Standards (IFRS) - Issues and Solutions for the Pharmaceutical and Life Sciences Industries – Vol I & II UPDATES - April 2008

IFRS - Issues and Solutions for the Pharmaceuticals and Life Sciences Industries - Vol III - January 2008

US GAAP - Issues and Solutions for the Pharmaceuticals and Life Sciences Industries

A review of the implementation of IFRS in the pharmaceuticals and life sciences industries

The application of IFRS in the life sciences sector within Europe

IFRS and its impact on financial reporting for the life sciences sector

Applying IFRS in the pharmaceutical sector - October 2005
Pharmaceuticals industry survey results - July 2005

Part 1. China: Prescription for growth - November 2004
Part 2. Latin America: Prescription for growth - May 2005
Part 3. India: Prescription for growth - July 2005
Part 4. Central and Eastern Europe: Prescription for growth - November 2005
Part 5. The Russian Federation: Prescription for growth - May 2006
Part 6. Japan: Prescription for Growth - November 2006
Ind�stria Farmac�utica (Brazil) - April 2007

Privacy Legal About site provider Email Webmaster Territory sites Site map RSS

© 2002-2008 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.